GLP-1 receptor agonist
Topic
GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone to lower blood sugar levels, reduce appetite, and slow digestion. They are widely used in the treatment of type 2 diabetes and obesity, and are under study for other metabolic conditions. Common examples of this drug class include semaglutide, liraglutide, and tirzepatide.
11 episodes featuring GLP-1 receptor agonist
Modern Wisdom
Harvard geneticist David Sinclair projects human trials for cellular age reversal
The transition of cellular reprogramming from laboratory theory to human trials could fundamentally redefine how medicine treats age-related diseases.
Aug 24, 2026 · 2h 6m
Modern Wisdom
Harvard evolutionary biologist debunks popular diet myths and modern nutrition tribalism
Understanding how our evolutionary biology clashes with a predatory modern food environment is essential for escaping harmful diet trends and achieving long-term health.
Aug 15, 2026 · 2h 9m
This Week in Startups
Anthropic rumored to target massive trillion dollar valuation in upcoming IPO
This episode unpacks how massive AI valuations and physical automation are reshaping both public markets and labor-intensive industries like construction.
Aug 15, 2026 · 1h 20m
This Week in Startups
AI integration divides tech earnings as floating nuclear reactors eye data centers
As AI development demands unprecedented levels of power and data, the tech sector is forcing a massive rethink of both global energy infrastructure and national security boundaries.
Aug 7, 2026 · 1h 18m
The Joe Rogan Experience: Protect Our Parks
David Sinclair reveals how gene therapy and AI are reversing cellular aging
As biotechnology and artificial intelligence converge, the science of extreme longevity is transitioning from speculative theory to active human clinical trials.
Aug 7, 2026 · 2h 33m
This Week in Startups
VCs dissect Airtable acquisition and the new reality of startup valuations
This episode provides a rare look inside the VC playbook as firms adapt to lower startup valuations, secondary market pressures, and internal AI automation.
Aug 5, 2026 · 1h 13m
Huberman Lab Essentials
Dr. Tommy Wood outlines how physical and mental friction rewires the brain
Understanding how to actively trigger neuroplasticity through targeted exercise and cognitive challenges is essential for preventing age-related mental decline.
Jul 20, 2026 · 2h 41m
The Contrarians with Adam and Adir
Discount airlines and private equity face reckoning as consumer habits shift
Understanding how structural shifts in technology, consumer health, and debt markets are exposing vulnerabilities in legacy business models.
Jul 13, 2026 · 1h 49m
The Diary Of A CEO with Steven Bartlett
Dr. Stephanie Estima explains why standard fitness advice fails women
Most exercise and nutrition science is based on male data, leaving women with fitness protocols that can actively disrupt their hormones and joint health.
Jun 29, 2026 · 1h 37m
The Diary Of A CEO with Steven Bartlett
Systemic medical failures leave women without essential hormone and sexual healthcare
The widespread lack of medical training in female anatomy and hormone therapy leaves millions of women suffering from treatable physical pain and sexual dysfunction.
Jun 22, 2026 · 1h 50m
This Week in Startups
GRU Space plans lunar hotel using robotic brick manufacturing from topsoil
As SpaceX lowers the cost of space travel, startups are designing actual lunar infrastructure, even as geopolitical tensions and government interventions threaten to slow down the AI revolution on Earth.
Jun 15, 2026 · 1h 41m